Evidence mapPaperPMID 20609967Full record

SynthesisLancet (London, England)2010

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Emerging Risk Factors Collaboration, N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin and 9 more

Erratum issued 10 registry-linked trialsOpen access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Lancet (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 10 registered trials, which are not on this map. Cited by 2,203 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,203citing papers in PubMed, 11 pooled it
81.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01761318 phase4completedstarted 2013, after this paper: background citation

Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus

Ran2013Enrolled50Registered outcomes48Posted comparisons0ConditionsCardiovascular Disease, Diabetes Mellitus Type 2, Diastolic Dysfunction, Fatty LiverArmsliraglutide, Liraglutide - Placebo
Open the trial in the graph
NCT03771053 naunknown statusstarted 2018, after this paper: background citation

Intravascular Ultrasound Evaluation of the Intervention Effect of Simvastatin Combined With Ezetimibe on Coronary Borderline Lesion in Patients With Stable Angina Pectoris and Diabetes Mellitus Compared With Simvastatin Alone

Ran2018Enrolled240Registered outcomes7Posted comparisons0ConditionsCoronary Heart DiseaseArmsEzetimibe with simvastatin, simvastatin
Open the trial in the graph
NCT05136287 completedstarted 2022, after this paper: background citation

Semaglutide versus glp-1 receptor agonists. effectiveness , safety and quality of life in patients with diabetes mellitus 2. observational, prospective and multicenter study. several study.

Ran2022Enrolled140Registered outcomes7Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Quality of Life, Safety Issues, Weight LossArmsGLP-1 receptor agonist
Open the trial in the graph
NCT01898572 unknown statusnot on this mapstarted 2012, after this paper: background citation

Carotid Intimae-media Thickness (CIMT) and Carotid Plaque (CP) Presence as Risk Markers of Cardiovascular Disease at the Time of Type 2 Diabetes Diagnosis

TypeobservationalSponsorHospital Clinic of BarcelonaRan2012 to 2015Enrolled200ConditionsType II Diabetes Mellitus Without Mention of ComplicationArmsStandard care
NCT02933788 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients

TypeinterventionalSponsorKangbuk Samsung HospitalRan2016 to 2018Enrolled116ConditionsType 2 Diabetes MellitusArmsCilostazol, Acetylsalicylic acid
NCT04388280 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Functional and Anatomic Imaging Versus No Testing in Asymptomatic High-risk Diabetic Patients

TypeinterventionalSponsorClinical Centre of SerbiaRan2021 to 2023Enrolled400ConditionsAsymptomatic, High Risk, DiabetesArmsEchocardiography, CT angiography
NCT05804565 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Randomised Controlled Trial Comparing Metatarsal Method of Transection Using Bone Cutters or Bone Saw on Outcomes After Ray Amputation (MetaMet)

TypeinterventionalSponsorUniversity College Hospital GalwayRan2023 to 2024Enrolled40ConditionsDiabetic Foot, Gangrene, Limb, Wound InfectionArmsBone Saw, Bone Cutter
NCT05806190 completednot on this mapstarted 2023, after this paper: background citation

Frequency of Nocturnal Hypoglycaemia in Adults With Insulin-treated Diabetes and Adrenal Failure Using Prednisolone or Hydrocortisone: a Pilot Study

TypeobservationalSponsorImperial College Healthcare NHS TrustRan2023 to 2023Enrolled32ConditionsDiabetes Mellitus, Type 1, Adrenal Insufficiency, Diabetes Mellitus Type 2 - Insulin-TreatedArmsContinuous Glucose Monitoring
NCT06573060 unknown statusnot on this mapstarted 2023, after this paper: background citation

Impact of Glycemic Variability and Gut Microbiota and Metabolites on the Prognosis of Patients With Type 2 Diabetes Mellitus Combined With Acute Coronary Syndrome

TypeobservationalSponsorSecond Affiliated Hospital of Nanchang UniversityRan2023 to 2025Enrolled120ConditionsType 2 Diabetes Mellitus, Coronary Heart DiseaseArmsContinuous glucose monitoring
NCT06674161 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future

TypeobservationalSponsorKing Faisal Specialist Hospital & Research CenterRan2024 to 2030Enrolled80ConditionsMortality of Patients with CVD, Mortality of Patients with CVD and T2DM, Mortality of Patients with T2DM, Mortality of Patients with Neither
3 · Its place in the literature

Who cites it

2,203 citing papers in PubMed, 11 syntheses or guidelines pooled it, 5,069 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Review

2,143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Emerging Risk Factors CollaborationDepartment of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
N Sarwar
P Gao
S R Kondapally Seshasai
R Gobin
S Kaptoge
E Di Angelantonio
E Ingelsson
D A Lawlor
E Selvin
M Stampfer
C D A Stehouwer
S Lewington
L Pennells
A Thompson
N Sattar
I R White
K K Ray
J Danesh

Funding

Archiving the Charleston Heart StudyR03AG021162 · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2002 to 2002
$73k
British Heart Foundation RG/07/008/23674British Heart Foundation RG/08/013/25942British Heart Foundation RG/08/014British Heart Foundation RG/08/014/24067Medical Research Council G0100222Medical Research Council G0401527Medical Research Council G0600705Medical Research Council G0701619Medical Research Council G0902037Medical Research Council G19/35Medical Research Council G8802774Medical Research Council MC_U105260558Medical Research Council MC_U105260792Medical Research Council MC_U137686857Medical Research Council U.1052.00.006(60558)NCRR NIH HHS UL1 RR029882NIA NIH HHS R03 AG021162Wellcome Trust
6 · The paper itself

Abstract

backgroundUncertainties persist about the magnitude of associations of diabetes mellitus and fasting glucose concentration with risk of coronary heart disease and major stroke subtypes. We aimed to quantify these associations for a wide range of circumstances.

methodsWe undertook a meta-analysis of individual records of diabetes, fasting blood glucose concentration, and other risk factors in people without initial vascular disease from studies in the Emerging Risk Factors Collaboration. We combined within-study regressions that were adjusted for age, sex, smoking, systolic blood pressure, and body-mass index to calculate hazard ratios (HRs) for vascular disease.

findingsAnalyses included data for 698 782 people (52 765 non-fatal or fatal vascular outcomes; 8.49 million person-years at risk) from 102 prospective studies. Adjusted HRs with diabetes were: 2.00 (95% CI 1.83-2.19) for coronary heart disease; 2.27 (1.95-2.65) for ischaemic stroke; 1.56 (1.19-2.05) for haemorrhagic stroke; 1.84 (1.59-2.13) for unclassified stroke; and 1.73 (1.51-1.98) for the aggregate of other vascular deaths. HRs did not change appreciably after further adjustment for lipid, inflammatory, or renal markers. HRs for coronary heart disease were higher in women than in men, at 40-59 years than at 70 years and older, and with fatal than with non-fatal disease. At an adult population-wide prevalence of 10%, diabetes was estimated to account for 11% (10-12%) of vascular deaths. Fasting blood glucose concentration was non-linearly related to vascular risk, with no significant associations between 3.90 mmol/L and 5.59 mmol/L. Compared with fasting blood glucose concentrations of 3.90-5.59 mmol/L, HRs for coronary heart disease were: 1.07 (0.97-1.18) for lower than 3.90 mmol/L; 1.11 (1.04-1.18) for 5.60-6.09 mmol/L; and 1.17 (1.08-1.26) for 6.10-6.99 mmol/L. In people without a history of diabetes, information about fasting blood glucose concentration or impaired fasting glucose status did not significantly improve metrics of vascular disease prediction when added to information about several conventional risk factors.

interpretationDiabetes confers about a two-fold excess risk for a wide range of vascular diseases, independently from other conventional risk factors. In people without diabetes, fasting blood glucose concentration is modestly and non-linearly associated with risk of vascular disease.

fundingBritish Heart Foundation, UK Medical Research Council, and Pfizer.

Indexed as

Diabetes ComplicationsAdultAgedBlood GlucoseCoronary DiseaseDiabetes MellitusFastingFemaleHumansMaleMiddle AgedRisk FactorsStrokeBlood Glucose

Identifiers

PMID20609967
PMCPMC2904878
OpenAlexW2147663252

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 4 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.